Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 4
1986 2
1987 1
1988 1
1989 4
1990 4
1991 2
1992 1
1993 5
1994 7
1995 2
1996 1
1997 1
1998 6
1999 1
2000 2
2001 3
2002 2
2003 4
2004 4
2005 11
2006 7
2007 6
2008 7
2009 5
2010 8
2011 7
2012 5
2013 1
2014 5
2015 4
2016 1
2017 4
2018 6
2019 6
2020 4
2021 13
2022 2
2023 4
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K; KEYNOTE-590 Investigators. Sun JM, et al. Among authors: maqueda ma. Lancet. 2021 Aug 28;398(10302):759-771. doi: 10.1016/S0140-6736(21)01234-4. Lancet. 2021. PMID: 34454674 Clinical Trial.
Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate.
Thambyrajah R, Maqueda M, Neo WH, Imbach K, Guillén Y, Grases D, Fadlullah Z, Gambera S, Matteini F, Wang X, Calero-Nieto FJ, Esteller M, Florian MC, Porta E, Benedito R, Göttgens B, Lacaud G, Espinosa L, Bigas A. Thambyrajah R, et al. Among authors: maqueda m. Nat Commun. 2024 Feb 21;15(1):1604. doi: 10.1038/s41467-024-45716-y. Nat Commun. 2024. PMID: 38383534 Free PMC article.
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development.
Thambyrajah R, Maqueda M, Fadlullah MZ, Proffitt M, Neo WH, Guillén Y, Casado-Pelaez M, Herrero-Molinero P, Brujas C, Castelluccio N, González J, Iglesias A, Marruecos L, Ruiz-Herguido C, Esteller M, Mereu E, Lacaud G, Espinosa L, Bigas A. Thambyrajah R, et al. Among authors: maqueda m. Nat Commun. 2024 Jun 1;15(1):4673. doi: 10.1038/s41467-024-48854-5. Nat Commun. 2024. PMID: 38824124 Free PMC article.
AS-48 bacteriocin: close to perfection.
Sánchez-Hidalgo M, Montalbán-López M, Cebrián R, Valdivia E, Martínez-Bueno M, Maqueda M. Sánchez-Hidalgo M, et al. Among authors: maqueda m. Cell Mol Life Sci. 2011 Sep;68(17):2845-57. doi: 10.1007/s00018-011-0724-4. Epub 2011 May 17. Cell Mol Life Sci. 2011. PMID: 21590312 Free PMC article. Review.
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.
García-Hernández V, Arambilet D, Guillén Y, Lobo-Jarne T, Maqueda M, Gekas C, González J, Iglesias A, Vega-García N, Sentís I, Trincado JL, Márquez-López I, Heyn H, Camós M, Espinosa L, Bigas A. García-Hernández V, et al. Among authors: maqueda m. EMBO Mol Med. 2023 Feb 8;15(2):e16554. doi: 10.15252/emmm.202216554. Epub 2023 Jan 4. EMBO Mol Med. 2023. PMID: 36597789 Free PMC article.
Advances in the preclinical characterization of the antimicrobial peptide AS-48.
Cebrián R, Martínez-García M, Fernández M, García F, Martínez-Bueno M, Valdivia E, Kuipers OP, Montalbán-López M, Maqueda M. Cebrián R, et al. Among authors: maqueda m. Front Microbiol. 2023 Feb 2;14:1110360. doi: 10.3389/fmicb.2023.1110360. eCollection 2023. Front Microbiol. 2023. PMID: 36819031 Free PMC article. Review.
Are bacteriocins underexploited? Novel applications for old antimicrobials.
Montalbán-López M, Sánchez-Hidalgo M, Valdivia E, Martínez-Bueno M, Maqueda M. Montalbán-López M, et al. Among authors: maqueda m. Curr Pharm Biotechnol. 2011 Aug;12(8):1205-20. doi: 10.2174/138920111796117364. Curr Pharm Biotechnol. 2011. PMID: 21470151 Review.
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
Oh DY, Maqueda MA, Quinn DI, O'Dwyer PJ, Chau I, Kim SY, Duran I, Castellano D, Berlin J, Mellado B, Williamson SK, Lee KW, Marti F, Mathew P, Saif MW, Wang D, Chong E, Hilger-Rolfe J, Dean JP, Arkenau HT. Oh DY, et al. Among authors: maqueda ma. BMC Cancer. 2023 Nov 3;23(1):1056. doi: 10.1186/s12885-023-11539-1. BMC Cancer. 2023. PMID: 37919668 Free PMC article. Clinical Trial.
Genetic features of circular bacteriocins produced by Gram-positive bacteria.
Maqueda M, Sánchez-Hidalgo M, Fernández M, Montalbán-López M, Valdivia E, Martínez-Bueno M. Maqueda M, et al. FEMS Microbiol Rev. 2008 Jan;32(1):2-22. doi: 10.1111/j.1574-6976.2007.00087.x. Epub 2007 Nov 20. FEMS Microbiol Rev. 2008. PMID: 18034824 Free article. Review.
152 results